BACKGROUND: Angiogenesis has been attributed to be a well-recognized aspect of human cancer biology. As such, proteinase-activated receptor (PAR)-1, endostatin (ES) and interleukin-8 (IL-8) mediate the regulation of early-onset angiogenesis and in turn impact the process of tumor-growth and disease progression. PATIENTS AND METHODS: Formalin-fixed paraffin-embedded tissues were obtained from 137 patients with localized gastric cancer at University of Southern California and Memorial Sloan-Kettering Cancer Center medical facilities. DNA was extracted and genotyping was carried out using PCR-restriction fragment length polymorphism-based protocols. RESULTS: In false discovery rate-adjusted univariate analysis, PAR-1 -506 ins/del (P < 0.001), ES +4349 G>A (P = 0.004), and IL-8 -251 T>A (P < 0.0001) were associated with time to tumor recurrence (TTR). Further, PAR-1 -506 ins/del and IL-8 -251 were associated with overall survival (OS). After adjusting for covariates, IL-8 remained significantly associated with TTR (adjusted P = 0.003) and OS (adjusted P = 0.049), whereas ES was significantly associated with TTR (adjusted P = 0.026). CONCLUSIONS: Polymorphisms in PAR-1, ES, and IL-8 may serve as independent molecular prognostic markers in patients with localized gastric adenocarcinoma. The assessment of the patients' individual risk on the basis of interindividual genotypes may therefore help to identify patient subgroups at high risk for poor clinical outcome.
BACKGROUND: Angiogenesis has been attributed to be a well-recognized aspect of humancancer biology. As such, proteinase-activated receptor (PAR)-1, endostatin (ES) and interleukin-8 (IL-8) mediate the regulation of early-onset angiogenesis and in turn impact the process of tumor-growth and disease progression. PATIENTS AND METHODS: Formalin-fixed paraffin-embedded tissues were obtained from 137 patients with localized gastric cancer at University of Southern California and Memorial Sloan-Kettering Cancer Center medical facilities. DNA was extracted and genotyping was carried out using PCR-restriction fragment length polymorphism-based protocols. RESULTS: In false discovery rate-adjusted univariate analysis, PAR-1-506 ins/del (P < 0.001), ES +4349 G>A (P = 0.004), and IL-8 -251 T>A (P < 0.0001) were associated with time to tumor recurrence (TTR). Further, PAR-1-506 ins/del and IL-8 -251 were associated with overall survival (OS). After adjusting for covariates, IL-8 remained significantly associated with TTR (adjusted P = 0.003) and OS (adjusted P = 0.049), whereas ES was significantly associated with TTR (adjusted P = 0.026). CONCLUSIONS: Polymorphisms in PAR-1, ES, and IL-8 may serve as independent molecular prognostic markers in patients with localized gastric adenocarcinoma. The assessment of the patients' individual risk on the basis of interindividual genotypes may therefore help to identify patient subgroups at high risk for poor clinical outcome.
Authors: Li Ma; Rafael Perini; Webb McKnight; Michael Dicay; Andre Klein; Morley D Hollenberg; John L Wallace Journal: Proc Natl Acad Sci U S A Date: 2004-12-22 Impact factor: 11.205
Authors: Wu Zhang; David J Park; Bo Lu; Dong Yun Yang; Michael Gordon; Susan Groshen; Jim Yun; Oliver A Press; Daniel Vallböhmer; Katrin Rhodes; Heinz-Josef Lenz Journal: Clin Cancer Res Date: 2005-01-15 Impact factor: 12.531
Authors: S Even-Ram; B Uziely; P Cohen; S Grisaru-Granovsky; M Maoz; Y Ginzburg; R Reich; I Vlodavsky; R Bar-Shavit Journal: Nat Med Date: 1998-08 Impact factor: 53.440
Authors: Yan Ning; Philipp C Manegold; Young Kwon Hong; Wu Zhang; Alexandra Pohl; Georg Lurje; Thomas Winder; Dongyun Yang; Melissa J LaBonte; Peter M Wilson; Robert D Ladner; Heinz-Josef Lenz Journal: Int J Cancer Date: 2011-05-01 Impact factor: 7.396
Authors: Rihong Zhai; Yang Zhao; Geoffrey Liu; Monica Ter-Minassian; I-Chen Wu; Zhaoxi Wang; Li Su; Kofi Asomaning; Feng Chen; Matthew H Kulke; Xihong Lin; Rebecca S Heist; John C Wain; David C Christiani Journal: Cancer Date: 2011-07-12 Impact factor: 6.860
Authors: M J Labonte; P M Wilson; D Yang; W Zhang; R D Ladner; Y Ning; A Gerger; P O Bohanes; L Benhaim; R El-Khoueiry; A El-Khoueiry; H-J Lenz Journal: Ann Oncol Date: 2011-10-11 Impact factor: 32.976
Authors: Y-T Chionh; G Z Ng; L Ong; A Arulmuruganar; A Stent; M A Saeed; J Lk Wee; P Sutton Journal: Mucosal Immunol Date: 2014-05-28 Impact factor: 7.313
Authors: Silvia Sedda; Irene Marafini; Roberta Caruso; Francesco Pallone; Giovanni Monteleone Journal: World J Gastroenterol Date: 2014-09-14 Impact factor: 5.742